FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4521211000001103: Pergolide 250microgram tablets 57 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21334701000001117 Pergolide 250microgram tablets 57 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21334801000001114 Pergolide 250microgram tablets 57 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pergolide 250microgram tablets 57 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has VMP Pergolide 250microgram tablets true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has VMP Pergolide 250microgram tablets false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Is pack of Product containing precisely pergolide 250 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has active ingredient Pergolide mesilate false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has active ingredient Pergolide false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has VMP Product containing precisely pergolide 250 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has specific active ingredient Pergolide mesilate true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets 57 tablet Has basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Is a True Pergolide 250microgram tablets 57 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start